These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6091394)
61. [Neuropathology of longstanding subacute myelo-optico-neuropathy (SMON): an autopsy case of SMON with duration of 28 years]. Konno H; Takase S; Fukui T No To Shinkei; 2001 Sep; 53(9):875-80. PubMed ID: 11596484 [TBL] [Abstract][Full Text] [Related]
62. Clioquinol and neurological disease. Br Med J; 1971 May; 2(5757):291-2. PubMed ID: 4252528 [No Abstract] [Full Text] [Related]
63. Clioquinol neurotoxicity among multiple sclerosis patients? Herxheimer A; Bursill M J R Coll Gen Pract; 1983 Aug; 33(253):535-6. PubMed ID: 6224932 [No Abstract] [Full Text] [Related]
65. [A case of delayed myeloneuropathy due to malathion intoxication]. Komori T; Yamane K; Nagayama T; Shibata K; Nozaki H; Takeuchi M No To Shinkei; 1991 Oct; 43(10):969-74. PubMed ID: 1665979 [TBL] [Abstract][Full Text] [Related]
66. Repetitive Transcranial Magnetic Stimulation for Dysesthesia Caused by Subacute Myelo-Optico-Neuropathy: A Case Report. Mano T; Kuru S Case Rep Neurol; 2020; 12(2):169-174. PubMed ID: 32595479 [TBL] [Abstract][Full Text] [Related]
67. [Persistence of the neurologic risk of clioquinol]. Devoize JL; Calmette I; Lavarenne J; Tournilhac M Presse Med; 1983 Nov; 12(40):2532. PubMed ID: 6227908 [No Abstract] [Full Text] [Related]
68. Letter: Watch out for combinations. Smith DL Pediatrics; 1976 Jan; 57(1):163. PubMed ID: 128731 [No Abstract] [Full Text] [Related]
69. [Clioquinol use for Dientamoeba fragilis infections is questionable]. van Hunsel F; van Nieuwkoop C; Stricker BHC Ned Tijdschr Geneeskd; 2017; 161():D1477. PubMed ID: 28880141 [TBL] [Abstract][Full Text] [Related]
70. Improving Anxiety in Subacute Myelo-optico-neuropathy (SMON) after an Automated Telephone Call Service. Ohta Y; Hishikawa N; Sato K; Takemoto M; Yamashita T; Doutare S; Abe K Intern Med; 2019 Apr; 58(8):1081-1085. PubMed ID: 30568131 [TBL] [Abstract][Full Text] [Related]
71. Clioquinol and related drugs. Br Med J; 1979 Sep; 2(6190):607. PubMed ID: 159088 [No Abstract] [Full Text] [Related]
74. Neuropathy and optic atrophy associted with halquinol. Hanson O; Herxheimer O Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110086 [No Abstract] [Full Text] [Related]
75. Prognosis of SMON patients. Sobue I; Aoki K; Ohtani M Jpn J Med Sci Biol; 1975; 28 Suppl():203-17. PubMed ID: 136538 [TBL] [Abstract][Full Text] [Related]
76. Epidemiological studies on subacute myelo-optico-neuropathy with abdominal symptoms (SMON) in epidemic area of Okayama Prefecture, Japan. XI. Epidemiological studies on SMON. Ogata M; Jitsunari F; Sunami S; Hayashi S Acta Med Okayama (1952); 1970 Aug; 24(4):435-45. PubMed ID: 4254198 [No Abstract] [Full Text] [Related]
77. Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report. Thivakaran T; Gamage R; Gunarathne KS; Gooneratne IK Neurologist; 2012 Jul; 18(4):226-8. PubMed ID: 22735254 [TBL] [Abstract][Full Text] [Related]
78. Neuropathy after clioquinol. McEwen LM Br Med J; 1971 Oct; 4(5780):169-70. PubMed ID: 4329646 [No Abstract] [Full Text] [Related]
80. [Bilateral optic atrophy in a one and one-half-year-old child possibly a result of administration of iodochlorhydroxyquinoline (Enterovioform)]. Drukker J; Lindenburg PA Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1618-20. PubMed ID: 4262826 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]